Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ePAD: Edoxaban vs Clopidogrel in PAD
NCT01802775Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Feb 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of edoxaban in Peripheral Arterial Disease (PAD), sponsored by Daiichi Sankyo Co., Ltd.. Started Feb 2013; status: completed.
02
Drugs
edoxaban
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT01802775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01802775.